Skip to main navigation Skip to search Skip to main content

Reporting of Patient Global Assessments in Atopic Dermatitis Randomized Controlled Trials

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)E7-E9
JournalDermatitis
Volume31
Issue number1
DOIs
StatePublished - Jan 1 2020

Funding

J.I.S. served as a consultant and/or advisory board member for Abbvie, Asana, Dermira, Eli Lilly, Galderma, GlaxoSmithKline, Glenmark, Kiniksa, Leo, Menlo, Pfizer, Regeneron-Sanofi, Realm, and Dermavant that granted honoraria; served as a speaker for Regeneron-Sanofi and received research grants from GlaxoSmithKline and Galderma. J.I.S. is supported by the Dermatology Foundation. K.R.P. has no funding or conflicts of interest to declare. J.I.S. had full access to all the data in the study and take responsibility for the integrity of the data and accuracy of the data analysis, did the study concept and design, did the acquisition of the data, and obtained funding. P.K.R. and J.I.S. drafted the article, did the critical revision of the article for important intellectual content, and did the statistical analysis.

Funders
Dermatology Foundation

    ASJC Scopus subject areas

    • Immunology and Allergy
    • Dermatology

    Cite this